Arrowhead Lead Scientific Advisor, Dr. Mauro Ferrari and Calando Pharmaceuticals’ siRNA Drug Delivery Platform …

Arrowhead Lead Scientific Advisor, Dr. Mauro Ferrari and Calando Pharmaceuticals’ siRNA Drug Delivery Platform …
Arrowhead Research Corporation (NASDAQ:ARWR) today announced that two articles of interest to Arrowhead stockholders appeared in the Houston Chronicle this week. An article published on May 24, entitled “Minute invaders that aid the body”, reports on the revolutionary potential of gene silencing and the pioneering role of the siRNA delivery system developed by Arrowhead majority-owned subsidiary …

Read more on SYS-CON Media